Oncology Clinical Trials in Canton, OH
As of August 2026, 54 paid clinical trials are recruiting for Oncology in Canton, Ohio. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
54 clinical trials for Oncology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
GEMINI-NSCLC: NSCLC Biomarker Study
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
XTX301 in Patients With Advanced Solid Tumors
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Study of SGR-1505 in Mature B-Cell Neoplasms
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Top Research Study Locations in Canton
Researchers run research studies in Canton, OH at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Aultman Health Foundation | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | 32 |
| Gabrail Cancer Center | Colorectal Neoplasms, Hematologic Malignancies, Myelofibrosis | 19 |
| Gabrail Cancer Center Research | Myelodysplastic Syndromes, Acute Myeloid Leukemia, Advanced Cancer | 14 |
| Aultman Hospital | Carcinoma, Non-Small-Cell Lung, Lung Cancer, Non-Small Cell Lung Cancer | 10 |
| Cleveland Clinic Mercy Hospital | Stage IVA Prostate Cancer AJCC v8, Acute Myelogenous Leukemia, Breast Cancer | 9 |
| GSK Investigational Site | Gastrointestinal Stromal Neoplasms, Lymphoma, Non-Hodgkin, Multiple Myeloma | 6 |
| Gabrail Cancer & Research Center | ALK-Positive Large B-Cell Lymphoma, Acneiform Eruption Due to Chemical, Breast Cancer | 5 |
| Gabrail Cancer Research Center | Solid Tumor, Advanced Cancer, Breast Cancer | 3 |
| NeuroScience Research Center, LLC | OSA, Parkinson Disease, Idiopathic Hypersomnia | 3 |
| Apex Clinical Research Center - Canton | Plaque Psoriasis | 2 |
| Apex Clinical Research Center, LLC | Hidradenitis Suppurativa (HS), Plaque Psoriasis | 2 |
| Gabrail Cancer and Research Center | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations | 2 |
| Neuro-Behavioral Clinical Research | Bipolar I Disorder, Schizophrenia | 2 |
| NeuroScience Research Center | Focal Epilepsy | 2 |
| Gastroenterology & Hepatology Specialists, Inc. | Ulcerative Colitis, Crohn's Disease | 2 |
| Alkermes Investigational Site | Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2 | 1 |
| Alkermes Investigator Site | Idiopathic Hypersomnia | 1 |
| Aultman | Epidermal Growth Factor Receptor Gene Mutation, Non Small Cell Lung Cancer, Stage III Lung Cancer | 1 |
| Aultman Cardiology Clinical Trials | Cardiovascular Disease | 1 |
| Aultman Hospital, Cardiovascular Consultants, Inc | Atherosclerotic Cardiovascular Disease, Obesity, Overweight | 1 |
| Aultman Medical Group | Cancer | 1 |
| Aultman Medical Group Hematology and Oncology | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Aultman Timken Family Cancer Center | Breast Cancer | 1 |
| Cleveland Clinic - Mercy Hospital | Triple-Negative Breast Cancer | 1 |
| Cleveland Clinic Mercy Hospital Cancer Center | Extensive-stage Small-cell Lung Cancer | 1 |
Active & Upcoming Studies in Canton (2026)
Recruiting trials in Canton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (85 active studies)
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · Phase 3 · Corbus Pharmaceuticals Inc.
- A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL · Phase 1, Phase 2 · GlaxoSmithKline
Cardiovascular (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Diabetes & metabolic (5 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Neurology & pain (4 active studies)
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Mental health & behavior (2 active studies)
- 52-week Open Label Safety-Tolerability Study · Phase 3 · LB Pharmaceuticals Inc.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Pediatric (1 active study)
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Common conditions studied in Canton
- Breast Cancer (7 active studies)
- Multiple Myeloma (5 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Ovarian Cancer (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (3 active studies)
Leading research sponsors in Canton
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- NRG Oncology
- AstraZeneca
- GlaxoSmithKline
Frequently asked questions
How many paid clinical trials are currently recruiting in Canton?
There are approximately 148 recruiting clinical trials in Canton, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Canton pay participants?
Most recruiting trials in Canton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Canton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Canton?
The most common conditions under active study in Canton include Breast Cancer (7), Multiple Myeloma (5), Carcinoma, Non-Small-Cell Lung (4), Ovarian Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Canton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Canton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Canton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Canton?
Recruiting research sites in Canton include Aultman Health Foundation, Gabrail Cancer Center, Gabrail Cancer Center Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Canton right now?
The largest active categories in Canton are Cancer & tumors (85), Cardiovascular (6), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.